Brief: Oncozenge Partners With Molteni Farmaceutici
28/03/2025 07:04
March 28 (Reuters) - Oncozenge AB ONCOZ.ST: ONCOZENGE AB ENTERS EXCLUSIVE AGREEMENT WITH MOLTENI FARMACEUTICI FOR COMMERCIALIZATION OF BUPIZENGE™ IN EUROPE PARTIES WILL CONTINUE TO EVALUATE MANUFACTURING CAPABILITIES AND ONCOZENGE WILL PROVIDE TIMELY UPDATES TO MARKET AS DEVELOPMENTS OCCUR Source text: ID:nWkr1TMmYQ Further company coverage: ONCOZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))